Ultimate Glucosamine
Natural health product licensed in Canada
- Other names
- Villicote
- Licence holder
- Wellesley Therapeutics Inc.
- NPN or DIN-HM
- 80033783
- Status
- Active licence
- Licence date
- 19 July 2012
- Revision date
- 20 October 2026
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | minimum: 14 years | minimum: 1 g ; maximum: 2 g | 3 Tous les jours |
| Adultes | minimum: 19 years | minimum: 2 g ; maximum: 3 g | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps promote a healthy intestinal lining. Could help to relieve joint pain associated with osteoarthritis. Could be a factor in the maintence of good cartilage and/or joint health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use this product if you are allergic to shellfish.
- Précautions et mises en garde
If you are pregnant or breastfeeding, please consult a health care practitioner prior to use of this product. Consult a health care practitioner if symptoms persist or worsen.
Source
Official Health Canada record, licence 80033783
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
No ingredient list for this product yet. Have it to hand? Photograph the ingredient list. Photograph the packaging